Urological cancer: The benefits of intermittent androgen-deprivation therapy

[1]  Donna L Berry,et al.  Intermittent versus continuous androgen deprivation in prostate cancer. , 2013, The New England journal of medicine.

[2]  Joseph L. Chin,et al.  Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy , 2013 .

[3]  J. Battermann,et al.  Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review , 2013, World Journal of Urology.

[4]  T. Tammela,et al.  The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer. , 2012, The Journal of urology.

[5]  P. Schellhammer,et al.  Intermittent (IAD) versus continuous androgen deprivation (CAD) in hormone sensitive metastatic prostate cancer (HSM1PC) patients (pts): Results of S9346 (INT-0162), an international phase III trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  C. Lawton,et al.  Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09 , 2011 .

[7]  A. Bono,et al.  Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group. , 2009, European urology.

[8]  A. Kibel.  Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group , 2009 .

[9]  U. Steiner,et al.  Randomised prospective study of intermittent versus continuous androgen suppression in advanced prostate cancer , 2007 .

[10]  P. Rubin,et al.  Early initiation of salvage hormone therapy influences survival in patients who failed initial radiation for locally advanced prostate cancer: A secondary analysis of RTOG protocol 86-10. , 2006, International journal of radiation oncology, biology, physics.

[11]  P. Bonnet,et al.  Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial. , 2002, Clinical prostate cancer.

[12]  S. Goldenberg,et al.  Effects of intermittent androgen suppression on androgen‐dependent tumors. Apoptosis and serum prostate‐specific antigen , 1993, Cancer.